Expertise
Seeding innovations for pressing health needs
Innovation drives everything we do to develop effective solutions for our partners as well as solve some of the hardest diagnostic challenges in global health.
Partnering with Global Access Diagnostics gives you access to our world-leading scientific team and Innovations Hub, designed to advance lateral flow technology to tackle urgent global health needs. From finding the very best reagent pairs to the engineering of superior assay choreography, we continue to pioneer work on the future of lateral flow tests, supporting a vision of connected diagnostics that are accessible to those who need them most.
Developing lateral flow tests bespoke to your needs
Our Assay Development Hub at Global Access Diagnostics offers a complete range of assay development services to researchers, developers, and manufacturers of rapid point-of-care assays and devices.
Our team of more than 40 scientists has extensive experience in dealing with monoplex or multiplex tests, device housing, and product design, both for unique test systems and our innovative enzyme activity detection (ELTABA) platform. We can help with everything from identifying the right proteins and custom antibody production to designing the most effective device and scaling up low-volume lateral flow manufacturing. Our work is carefully stage-gated, from proof of concept to launch. We review progress together and ensure we make the right decisions to develop your assay or product.
Supporting the local manufacture of diagnostics
Our team of expert process development and technical transfer scientists bridge the gap between innovation and impact. We work with partners in low- and middle-income country settings to build local R&D and lateral flow assay manufacturing capacity. We can provide full support with our quality and regulatory expertise and clinical trials team.
Global Access Diagnostics is committed to ensuring our innovations and tools get to those who need them most. This commitment is underpinned by our status as a social enterprise, which allows us to provide access to life-saving tools. We always prioritise impact and access above profit.
GET IN TOUCH
For sales inquiries please contact sales@globalaccessdx.com
For technical support please contact technicalsupport@globalaccessdx.com
Frequent testing is invaluable and so it is vital to find ways to drive down the cost of kits and increase production levels. As a social enterprise, GADx can transform this process because it ‘breaks the link’ of ‘having to make profit for shareholders’.
Paul Davis
Co-founder of Mologic and pioneer of lateral flow diagnostics.